1796568-94-9

Originally characterized as a "spleen colony-forming units (CFU-S) inhibitor" for its activity against hematopoietic pluripotent stem cell proliferationAc-SDKP (Goralatide) is an immunomodulatory and pro-angiogenic tetrapeptide derived from the N-terminal end of thymosin β4 (Tβ4 aa 1-4) via sequential enzymatic actions of meprin-α and prolyl-oligopeptidase (POP)while angiotensin converting enzyme (ACE) mediates Ac-SDKP degradation. In animal heartkidney and brain injury studiesAc-SDKP ameliorates end-organ damage by promoting angiogenesisas well as by reducing inflammation and fibrosis.